Prolium’s $50M Series A raise; COUR Pharma touts liver drug follow-upnews2026-03-03T15:32:03+00:00March 3rd, 2026|Endpoints News|
Chems market slide continues to accelerate as commodity prices surgenews2026-03-03T15:32:00+00:00March 3rd, 2026|Independent Commodity Intelligence Services (ICIS)|
Theravance ends R&D, lays off 50% of workers after Phase 3 failnews2026-03-03T15:00:39+00:00March 3rd, 2026|Endpoints News|
Boehringer Ingelheim tried to use a tempting, tough cancer target for liver disease. It didn’t worknews2026-03-03T14:32:05+00:00March 3rd, 2026|Endpoints News|
Citric acid cycle a ‘garbage compactor’ as well as an energy powerhousenews2026-03-03T14:30:00+00:00March 3rd, 2026|Chemistry World|
Corrected: Hims’ pharmacy partner won’t reintroduce GLP-1 pill pulled from marketnews2026-03-03T14:24:24+00:00March 3rd, 2026|Endpoints News|
ICER to CMS: Lower Takeda blockbuster’s price to Stelara’s levelnews2026-03-03T14:03:50+00:00March 3rd, 2026|Endpoints News|
CMS’ Chris Klomp on what it will take for AI to succeed in healthcarenews2026-03-03T14:00:45+00:00March 3rd, 2026|Endpoints News|
